Asthma in Adults Flashcards

1
Q

FEV1/FVC ratio?

A

Obstructive - so decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathology

A

Inflammatory condition characterised by bronchoconstriction by smooth muscle contraction and airway oedema (mucus)

Reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aetiology

A

Passive smoking
Maternal smoking - lungs don’t develop
Air pollution
Occupation - jobs exposing to dust, vapours, fumes
Airway hyper responsiveness - Type 1 hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms

A
SOB
Wheeze
Cough 
Chest tightness
Diurnal variability - timing 
Episodic 
Atopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signs

A
Tachypnoea 
Wheeze 
Eczema
Response to bronchodilators 
Peak flow returns to normal (reversible)
Obstructed spirometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Useful Investigations

A

CXR (hyperinflation, hyperlucent)
Skin prick test to measure serum IgE (assess atopy)
FBC (eosinophilia - atopy)
U+Es (renal function)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aims of treatment

A
No day/night symptoms 
No need for rescue meds
No asthma attack (Exacerbation) 
Normal lung function (no limitations)
FEV1 or PEF > 80% 
Minimal side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Non pharmacological management

A

Exercise
Smoking cessation
Weight management
Flu/pneumococcal vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacological management

A
Inhaled short acting B agonist - reliever 
Inhaled corticosteroid (ICS)
Inhaled LABA 

Add on:
Leukotriene receptor antagonists
Theophyllines
Oral steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benefits of inhalers

A
Small dose 
Delivered straight to airways and lungs
Onset of effect faster 
Low systemic exposure
Side effects less severe and less frequent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When to escalate treatment

A

If there is no response to inhaled LABA - stop LABA and increase dose of ICF

If benefit from LABA but control by patient is inadequate - continue LABA and increase ICS to medium dose. If still inadequate then consider trial of other therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute asthma sign

A

Can they complete sentence before breathlessness?

Hunch forward and shoulders raised to increase vol. into lungs

Wheezy, cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How to prevent acute asthma attack

A
Patient specific 
Know trigger (patients know their action plan and their signs)
Avoid delays 
Follow guidelines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Asthma attack features

A

PEF 33-50% of normal
RR > 25
HH > 110
Cant finish sentence in one breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What cause the narrowing of the airways?

A

Airway inflammation mediated by immune system cause bronchoconstriction, and releases ACh, histamine and leukotrienes from mast cells, eosinophils and macrophages and asthmatics usually have increased airway reactivity causing further narrowing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors

A

Genetic - atopy
Occupation
Smoking - decrease FEV1 and increase airway responsiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the genetic factors in the risk of developing asthma

A

Genetic tendency for IgE to respond to allergens

Immune response genes: IL-4 / 5, IgE
Airway gene: ADAM33

3x more likely to develop if mother has atopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What to look for in clinical history

A

PMH:
Childhood asthma, bronchitis
Hayfever

Drugs:
Current inhalers, check technique and compliance
B-blockers, aspirin, NSAIDs

FMH:
Atopic disease

PSH:
Smoking
Pets
Occupation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Interpretation of spirometry

A

FEV/FVC ratio <70%

FEV1 < 80% predicted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Use of PEF

A

Lung function in clinic may be normal, PEF used to look for variability in airflow obstruction

Peak flow meter and chart, twice daily for 2 weeks

Look for:
Morning/nocturnal dips
Decline over weeks/days
Variability > 20%

Can diagnose occupation asthma (lowest PEF during weekdays)

21
Q

What are the main investigations?

A

Spirometry
Pulmonary function test (to look for COPD)
Reversibility
PEF - if spirometry is normal

22
Q

Sign of life threatening acute severe asthma

A
Grunting 
Impaired consciousness, confusion, exhaustion
HR > 130 or bradycardic
Hypoventilating 
PEF < 33% best
Cyanosis 

Sao2 < 92% (no ventilation)
PaO2 < 60mmHg
PaCO2 normal

23
Q

Sign of asthma attack (fatal)

A

Raised PaCO2

24
Q

Step 1 in treatment

A

Start on inhaled short acting B2 agonist - relievers

Salbutamol (MDI, DPI)
Terbutaline (DPI)

25
Q

Step 2 in treatment of adults

A

Add low-dose ICS (200-800mg) - preventer

26
Q

Step 3 (add on therapies) in treatment of adults

A

Add inhaled long acting B2 agonist to ICS

27
Q

In step 3, what happens if there is no response to LABA?

A

Stop LABA and increase dose of ICS to 800mg

28
Q

Step 4 of treatment in adults

A

Consider trials of:
Increasing ICS to 2000mg
Addition of fourth drug - LTRA, theophylline, beta agonist tablet, LAMA

29
Q

Step 5 of treatment in adults

A

Use daily steroid TABLET
Maintain high dose of ICS
May refer patient to specialist

30
Q

Three oral therapies

A

Leukotriene receptor antagonist
Theophylline
Prednisolone

31
Q

Use of ICS criteria

A

If using inhaled B2 agonist > x3 a week
Waking 1 night a week
Sub-normal exercise tolerance

32
Q

Specialist options for treatment

A

Omalizumab (anti-IgE)
Mepolizumab (anti-interleukin-5)
Bronchial thermoplasty

33
Q

Response to mild/moderate acute asthma attack

A
Increase inhaler use 
Oral steroid 
Treat trigger
Early follow up plan
Back up plan
34
Q

Response to sever acute asthma attack

A
HOSPITAL 
Nebulisers - salbutamol, ipratroprium 
Oral/IV steroid
Magnesium (helps bronchoconstriction)
Aminophylline 
Know triggers - infection/allergen 
Complication - do CXR
35
Q

Benefit of inhalers over oral therapy

A

Direct delivery to target organ (airway and lungs)
Onset of effect faster
Minimal systemic exposure (adverse effect less)

36
Q

What is a pMDI?

A

Metered dose inhalers:

Delivers specific dose of drug by aerosol

37
Q

Advantages and disadvantages of pMDIs

A

Doesn’t require deep breath (low inspiratory flow)

But requires coordination for simultaneous push and inspiration - no effective for young and elderly

38
Q

What is a DPI?

A

Dry powder inhaler:
Requires high inspiratory flow
Less coordination required

39
Q

What can occupation expose a person to which would increase risk of developing asthma?

A

Isocyanates (paint)
Grains
Enzymes
Crustaceans

40
Q

Describe the effect of maternal smoking during pregnancy in asthma

A

Nicotine causes modification in oocyte in female foetus’

Decrease FEV1
Increase wheeze
Increase airway response
Increase asthma and severity

41
Q

What is the ‘grandmother’ effect of asthma risk?

A

Mother smoked: 50% chance of developing
Maternal grandmother smoked: 150%
Mother and maternal smoked: increased further

42
Q

What are conditions that cause general airflow obstruction?

A
Asthma (reversible AFO)
COPD (irreversible AFO)
Bronchiectasis 
Bronchiolitis 
CF
43
Q

What is investigated in pulmonary lung function tests?

A

Lung volumes:
Increase residual volume
Increase total lung capacity
RV/TLC > 3-%

CO Gas Transfer

44
Q

How do you intemperate reversibility to bronchodilator investigation?

A

Baseline and then 15mins post salbutamol

Significant reversibility: FEV1 >200ml and FEV1 > 15% of baseline

45
Q

What are the steps in investigations if spirometry is obstructed?

A
  1. Spirometry = obstructed
  2. Pulmonary function test
  3. Reversibility to bronchodilators
  4. Reversibility to corticosteroids
46
Q

How is reversibility to corticosteroids investigation carried out?

A

0.6mg/kg Predinisolone for 2 weeks
Peak flow chart and meter
Baseline and 2 week spirometry

47
Q

What are the steps in investigation if the spirometry is normal?

A
  1. Spirometry = normal
  2. Peak flow meter and chart, twice a day for 2 weeks
  3. ‘Optional’ investigation for SPECIALIST - airway responsiveness to histamine/exercise and exhaled nitric oxide (FeNO)
48
Q

What can a CXR show in asthma?

A

Hyperinflated
Hyperlucent

(No effusion, collapse, opacities, interstitial changes)